top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.

Biblioteca

MARC Lista (tabellare)
Application of nanotechnology in food science, processing and packaging / / Chukwuebuka Egbuna [and three others], editors
Application of nanotechnology in food science, processing and packaging / / Chukwuebuka Egbuna [and three others], editors
Pubbl/distr/stampa Cham, Switzerland : , : Springer Nature Switzerland AG, , [2022]
Descrizione fisica 1 online resource (266 pages)
Disciplina 664
Soggetto topico Food
Food industry and trade
Nanotechnology
ISBN 3-030-98820-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910568241703321
Cham, Switzerland : , : Springer Nature Switzerland AG, , [2022]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Dietary phytochemicals : a source of novel bioactive compounds for the treatment of obesity, cancer and diabetes / / Chukwuebuka Egbuna, Sadia Hassan, editors
Dietary phytochemicals : a source of novel bioactive compounds for the treatment of obesity, cancer and diabetes / / Chukwuebuka Egbuna, Sadia Hassan, editors
Pubbl/distr/stampa Cham, Switzerland : , : Springer, , [2021]
Descrizione fisica 1 online resource (262 pages)
Disciplina 615.321
Soggetto topico Phytochemicals - Health aspects
Fitoquímica
Nutrició
Biotransformació (Metabolisme)
Càncer
Obesitat
Diabetis
Soggetto genere / forma Llibres electrònics
ISBN 3-030-72999-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Intro -- Preface -- Contents -- Etiology of Obesity, Cancer, and Diabetes -- 1 Introduction -- 2 Obesity -- 2.1 Etiology of Obesity -- 2.2 Biological Factors -- 2.2.1 Genetics -- Monogenic Obesity -- Syndromic Obesity -- Polygenic Obesity -- 2.2.2 Brain-gut Axis -- 2.2.3 Prenatal Determinants -- 2.2.4 Pregnancy -- 2.2.5 Menopause -- 2.2.6 Physical Disability -- 2.2.7 Gut Microbiome -- 2.3 Environmental Factors -- 2.3.1 Obesogenic Environment -- 2.3.2 Socio-Economic Factors -- 2.3.3 Environmental Chemicals and Obesity -- 2.4 Behavioral Factors -- 2.4.1 Increased Calorie Intake and Eating Habits -- 2.4.2 Sedentary Lifestyle and Less Physical Activity -- 2.4.3 Insufficient Sleep -- 2.4.4 Quitting Smoking -- 3 Cancer -- 3.1 Major Types of Cancer -- 3.2 Causes of Cancer -- 3.2.1 Diet and Physical Activity -- 3.2.2 Use of Addictive Substances -- 3.2.3 Sex and Reproductive Health -- 3.2.4 Environmental Factors -- 3.2.5 Genetics -- 4 Diabetes Mellitus -- 4.1 Causes of Type 1 Diabetes Mellitus -- 4.1.1 Genetic Susceptibility Factors -- 4.1.2 Virus-Related Contagions -- 4.1.3 Role of Environment -- 4.2 Etiology of Type 2 Diabetes Mellitus -- 5 Conclusion -- References -- Pathophysiology of Obesity and Diabetes -- 1 Introduction -- 2 Obesity and Body Mass Index -- 3 Pathophysiology of Obesity -- 3.1 Development of Fat Cells -- 3.2 Fat Cell Metabolism -- 3.3 Oxidative Stress -- 3.4 Weight Stigma -- 4 Role of Different Factors in the Pathophysiology of Obesity -- 4.1 Pathophysiology of Obesity and the Role of Autonomic Nervous System -- 4.2 Osteopontin and Obesity -- 4.3 Obesity and Renal Disease -- 5 Maternal Obesity -- 6 Potential Role of Gut Inflammation in Disease Development -- 7 Childhood Obesity -- 8 Pathophysiology of Diabetes -- 8.1 Etiology of Diabetes -- 8.2 Role of Genetics in Development of T2DM.
8.3 Role of Environmental Determinants in the Development of T2DM -- 8.4 Insulin Resistance -- 8.5 The Role of Glucagon -- 8.6 Somatostatin -- 9 Conclusion -- References -- Pathophysiology of Obesity and Cancer: Drugs and Signaling Targets -- 1 Introduction -- 2 Pathophysiology of Obesity and Cancer -- 3 History of Anti-obesity Drugs -- 4 How to Treat Obesity? -- 5 Different Targets in Brain to Treat Obesity -- 5.1 Serotoninergic System -- 5.2 Noradrenergic System -- 5.3 Dopaminergic System -- 6 Link Between Obesity and Cancer -- 7 Drugs Targeting Cancer Cells -- 8 Drugs Targeting the Tumor Microenvironment's Cellular and Molecular Components -- 9 Changes in the Pharmacokinetics -- 10 Changes in Microbiota -- 11 Combination Therapy -- 12 Conclusion -- References -- Peptides Involved in Body Weight Regulation -- 1 Introduction -- 2 Appetite, Food Intake, and Obesity -- 3 Peptides and Body Weight -- 3.1 Effects of Hormonal Peptides -- 3.1.1 Orexigenic Peptides -- 3.1.2 Anorexigenic Peptides -- 3.1.3 Effects of Hypothalamic Peptides -- 3.2 Bioactive Peptides and Body Weight -- 4 Conclusion -- References -- Insulin Resistance: A Link Between Obesity and Cancer -- 1 Introduction -- 2 Obesity and Cancer -- 3 Diabetes and Cancer -- 4 Obesity and Diabetes -- 5 Mechanism Linking Insulin Resistance to Obesity and Cancer -- 6 Drugs to Treat Insulin Resistance -- 6.1 Metformin -- 6.2 Thiazolidinediones -- 6.3 Insulin Analogues -- 7 Challenges in Prevention and Treatment -- 8 Conclusion -- References -- Role of Cytoskeletal Protein, Actin in Various Diseases -- 1 Introduction -- 2 Microfilaments or Actin Filaments -- 2.1 Role in Cancer Metastasis and Tumor Angiogenesis -- 2.2 Role in Cytokinesis -- 2.3 Role in Cellular Signaling and Transport -- 2.4 Role in Immunodeficiency -- 2.5 Role in Fertilization of Eggs -- 2.6 Role in Neuronal Plasticity.
2.7 Role in Neurodegenerative Diseases -- 2.8 Role in Epigenetic Control -- 2.9 Role in Muscle Contraction -- 3 Conclusions -- References -- Diabetes Mellitus and it Management with Plant-Based Therapy -- 1 Introduction -- 2 Classification of Diabetes -- 2.1 Type I Diabetes Mellitus (T1DM) -- 2.2 Type II Diabetes Mellitus (T2DM) -- 2.3 Gestational DM (GDM) -- 3 Risk Factors of Diabetes -- 4 Pathophysiology -- 5 Screening and Diagnosis -- 6 Management -- 6.1 Through Lifestyle and Diet Modification -- 6.2 Pharmacological Agents -- 6.3 Plant Based Therapy -- 6.3.1 Mechanisms Underlying Herbal Anti-Diabetic Therapies -- 6.3.2 Classification of Plant-Based Anti-Diabetics -- 7 Conclusion -- References -- Fruits and Vegetables as Sources of Functional Phytochemicals for the Prevention and Management of Obesity, Diabetes, and Cancer -- 1 Introduction -- 2 Classification of Phytochemicals -- 2.1 Polyphenols -- 2.2 Terpenoids -- 2.3 Thiols -- 3 Health Benefits and Nutritional Value of Certain Fruits and Vegetables -- 3.1 Tomatoes -- 3.2 Grapes and Berries -- 3.3 Nuts -- 3.4 Citrus -- 3.5 Brassica Vegetables -- 3.6 Mushrooms -- 3.7 Kiwi -- 3.8 Cladodes -- 3.9 Carrots -- 3.10 Potatoes -- 3.11 Onion and Garlic -- 4 The Effect of Consuming Fruits and Vegetables on Some Diseases -- 4.1 Cancer -- 4.2 Obesity -- 4.3 Diabetes -- 5 Conclusion -- References -- Spices for Diabetes, Cancer and Obesity Treatment -- 1 Introduction -- 2 Anti-diabetic Effect of Spices -- 2.1 Fenugreek -- 2.2 Cinnamon -- 2.3 Garlic and Onion -- 2.4 Turmeric -- 2.5 Cumin Seeds -- 2.6 Ginger -- 3 Spices in the Treatment of Cancer -- 3.1 Basil -- 3.2 Caraway -- 3.3 Cardamom -- 3.4 Rosemary -- 3.5 Cumin -- 3.6 Turmeric -- 3.7 Garlic -- 3.8 Black Pepper -- 3.9 Red Chili -- 3.10 Ginger -- 3.11 Saffron -- 4 Spices in the Treatment of Obesity -- 4.1 Ginger -- 4.2 Turmeric -- 4.3 Garlic.
4.4 Red Pepper -- 5 Conclusion -- References -- MicroRNAs as Targets of Dietary Phytochemicals in Obesity and Cancer -- 1 Introduction -- 2 Phytochemical Modulated miRNAs and Its Role in Obesity -- 3 MicroRNAs as Phytochemicals Targets in Carcinogenesis -- 4 Dietary Phytochemicals and miRNA -- 4.1 Resveratrol -- 4.2 Genistein -- 4.3 Conjugated Linoleic Acids -- 4.4 Cinnamic Acid and Cinnamaldehyde -- 4.5 Ajoene -- 4.6 Curcumin -- 4.7 Epigallocatechin-3-Gallate -- 4.8 Quercetin -- 5 Conclusion -- References -- Natural Phenolic Compounds as Anti-obesity and Anti-cardiovascular Disease Agent -- 1 Introduction -- 2 Effects of Natural Phenolic Compounds on Oil and Fat Metabolism -- 3 Binding Bile Salt to Inhibit Emulsification of Lipids -- 3.1 In Vitro Studies -- 4 Pancreatic Lipase Inhibition -- 4.1 In Vitro Studies -- 4.2 In Silico Modeling Studies -- 4.3 Increase Fecal Lipid Excretion -- 4.4 Animal Models -- 4.5 Clinical Research -- 5 Gut Microbiota as Potential Targets -- 6 Reduction of Lipogenesis and Inflammation in Adipose Tissue and Liver -- 6.1 In Vitro Studies by Cell Models -- 6.2 Animal Models -- 7 Suppression of Lipogenic Enzyme Fatty Acid Synthase (FAS) in Cell -- 7.1 Cell Model -- 7.2 Animal Models -- 8 Increase of Lipolysis in Cell -- 9 Inhibition of Adipocyte Differentiation and Growth -- 10 Anti-atherosclerosis by Natural Phenolic Compounds -- 11 Conclusion -- References -- Harnessing the Potential of Phytochemicals for Breast Cancer Treatment -- 1 Introduction -- 2 Statistical Evidence Including the Indian Scenario -- 3 Current Treatments Strategies for Breast Cancer -- 3.1 Chemotherapy -- 3.2 Surgery -- 3.3 Gene Therapy -- 3.4 Oncogenes Inactivation -- 3.5 Augmentation of Tumor Suppresser Genes -- 3.5.1 BRCA1 and BRCA2 -- 3.5.2 Androgen Receptor -- 3.5.3 Immunomodulation -- 3.5.4 Endocrine (Antihormonal) Treatment.
3.5.5 Inclination Towards Phytochemicals -- 4 Phytochemicals for Breast Cancer Therapy -- 4.1 Plumbagin -- 4.2 Apigenin -- 4.3 Isothiocyanate -- 4.4 Quercetin -- 4.5 Curcumin -- 4.6 Catechins -- 4.7 Lycopene -- 4.8 Hesperidin -- 4.9 Anthocyanin -- 4.10 Colchicine Alkaloid -- 4.11 Polyphyllin D -- 4.12 Genistein -- 4.13 Resveratrol -- 4.14 Berberine -- 5 Pharmaceutical Compounding of Phytochemicals -- 6 Conclusion -- References -- Index.
Record Nr. UNINA-9910495214003321
Cham, Switzerland : , : Springer, , [2021]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Food and agricultural byproducts as important source of valuable nutraceuticals / / Chukwuebuka Egbuna, Barbara Sawicka, Johra Khan, editors
Food and agricultural byproducts as important source of valuable nutraceuticals / / Chukwuebuka Egbuna, Barbara Sawicka, Johra Khan, editors
Pubbl/distr/stampa Cham, Switzerland : , : Springer, , [2022]
Descrizione fisica 1 online resource (257 pages)
Disciplina 664
Soggetto topico Food waste - Recycling
Functional foods
ISBN 3-030-98760-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910584479303321
Cham, Switzerland : , : Springer, , [2022]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Functional Foods and Nutraceuticals : Bioactive Components, Formulations and Innovations / / edited by Chukwuebuka Egbuna, Genevieve Dable Tupas
Functional Foods and Nutraceuticals : Bioactive Components, Formulations and Innovations / / edited by Chukwuebuka Egbuna, Genevieve Dable Tupas
Edizione [1st ed. 2020.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020
Descrizione fisica 1 online resource (642 pages)
Disciplina 613.2
Soggetto topico Food—Biotechnology
Nutrition
Microbiology
Food Science
Food Microbiology
ISBN 9783030423193
3030423190
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Foreword -- Preface -- Part I: Introduction to functional foods and nutraceuicals -- Chapter 1: Functional foods and health benefits -- Chapter 2: Bioavailability of Nutrients and Safety Measurements -- Part II: Components of functional foods -- Chapter 3: Polyphenols and carotenoids as functional Bioactives -- Chapter 4: Bioactive carbohydrates and sources -- Chapter 5: Bioactive peptides and sources -- Chapter 6: Fats and oils as sources of bioactive molecules -- Chapter 7: Micronutrients fortifications: Vitamins and minerals -- Chapter 8: Usefulness of prebiotics, probiotics, and synbiotics in improving health status -- Chapter 9: Cereals and grains as functional food in Unani system of medicine -- Chapter 10: Soya beans and other plant protein products -- Chapter 11: Honey., Chapter 12: Mushrooms -- Chapter 13: Beverages: Cocoa and other caffeine products -- Chapter 14: Milk and milk products -- Chapter 15: Fruits and vegetables -- Chapter 16: Fish and fish products -- Chapter 17: Medical foods and infant formulas -- Part III: Safety Concerns and way forward -- Chapter 18: Nutraceutical stability, adulteration and way forward -- Chapter 19: Good manufacturing practices and safety issues in functional food industries -- Chapter 20: Food preservation concerns.
Record Nr. UNINA-9910416140903321
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Handbook of Agricultural Biotechnology, Volume 5 : Nanobiofertilizers
Handbook of Agricultural Biotechnology, Volume 5 : Nanobiofertilizers
Autore Adetunji Charles Oluwaseun
Edizione [2nd ed.]
Pubbl/distr/stampa Newark : , : John Wiley & Sons, Incorporated, , 2024
Descrizione fisica 1 online resource (595 pages)
Altri autori (Persone) EgbunaChukwuebuka
FicaiAnton
IjabadeniyiOluwatosin Ademola
Collana Handbook of Agricultural Bionanobiotechnology Series
Soggetto topico Agricultural biotechnology
Nanobiotechnology
ISBN 9781394211548
1394211546
9781394211524
139421152X
9781394211531
1394211538
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Series Page -- Title Page -- Copyright Page -- Contents -- Preface -- Chapter 1 Application of Nanobiofertilization for Bioremediation and Ecorestoration of Polluted Soil/Farmland -- 1.1 Introduction -- 1.2 Nanoparticles -- 1.2.1 Nanoparticles as Nano-Adsorbents -- 1.2.2 Nanobiofertilizers -- 1.2.3 Biosynthesis of Nanoparticles -- 1.2.4 Microbe-Mediated Synthesis -- 1.2.5 Plant-Mediated Synthesis -- 1.3 Nanobiofertilization in Bioremediation -- 1.3.1 Mechanism of NPs-Microbes Interaction in Pollutant Bioremediation -- 1.3.2 Plant and Nanoparticle-Based Interaction Mechanism in Pollutant Bioremediation -- 1.4 Application of Nanobiofertilization in Bioremediation -- 1.4.1 Heavy Metals Removal -- 1.4.2 Removal of Hydrocarbon -- 1.4.3 Removal of Colored Dyes -- 1.4.4 Removal of Antiseptics and Antibiotics -- 1.4.5 Nano-Phytoremediation of Polluted Soils -- 1.4.6 Removal of Organic Pollutants -- 1.4.7 Removal of Heavy Metal -- 1.5 Environmental Distress -- 1.6 Conclusion -- References -- Chapter 2 Influence of Nanobiofertilizer on Plant Yield and Growth -- 2.1 Introduction -- Nanobiofertilizer -- Composition of Nanobiofertilizer -- Mechanisms of Nutrient Delivery and Enhanced Bioavailability -- Seed Priming (Nanopriming) -- Soil-Based Application -- Nanobiofertilizer Plant System Interaction -- Impact of Nanobiofertilizer on Plant Biomass -- Factors Contributing to Enhanced Plant Growth -- Comparison of Biomass Enhancement with Traditional Fertilizers -- Nanobiofertilizer-Induced Biomass and Chlorophyll Content Enhancement -- Crop-Specific Responses to Nanobiofertilizers -- Case Studies Highlighting Positive Outcomes on Various Crops -- Environmental and Economic Considerations on the Use of Nanobiofertilizers -- Comparison of Nanobiofertilizers with Traditional Fertilizers in Terms of Cost and Effectiveness.
Potential Long-Term Benefits for Soil Health and Ecosystem -- Addressing Concerns Related to Nanoparticle Toxicity and Accumulation -- Need for Standardized Testing Protocols and Safety Assessments -- Exploration of Innovative Nanobiofertilizer Formulations and Delivery Methods -- Strategies for Incorporating Nanobiofertilizers into Existing Farming Systems -- Synergistic Effects of Combining Nanobiofertilizers with Other Sustainable Practices -- Practical Considerations for Large-Scale Implementation -- Potential to Revolutionize Agriculture and Contribute to Food Security -- Call to Action for Continued Research, Development, and Adoption of Nanobiofertilizers -- Conclusion -- References -- Chapter 3 Effect of Bionanofertilizer on Proximate Composition of Crops -- 3.1 Introduction -- 3.2 Biological Synthesis of Nanofertilizers -- 3.2.1 Bacterial-Based Nanosynthesis -- 3.2.2 Fungal-Based Nanosynthesis -- 3.2.3 Algal-Based Nanosynthesis -- 3.2.4 Plant-Based Nanosynthesis -- 3.3 Composition of Bionanofertilizers -- 3.3.1 Macronutrient Bionanofertilizer -- 3.3.2 Micronutrient Bionanofertilizer -- 3.3.3 Hybrid Bionanofertilizers -- 3.4 Properties of Bionanofertilizers -- 3.4.1 Efficient Nutrient Release and Use -- 3.4.2 Maintenance of Equilibrium Between Nutrient Demand and Nutrient Supply -- 3.4.3 Enhancement of Soil Heterogeneity and Reduction of Environmental Pollution -- 3.4.4 Improvement of Soil Water Retention Capacity -- 3.5 Effect of Bionanofertilizers of Proximate Parameters of Crops -- 3.6 Conclusion and Future Direction -- References -- Chapter 4 The Role of Policy Maker, Relevant Stakeholders and Government Agency in Translating Nanobiofertilizer Research into Policy -- 4.1 Introduction -- 4.2 Views of the Dangers of Nanotechnology and Confidence in Stakeholders -- 4.3 Policy Making Process.
4.4 Benefits of Agencies in the Nanoproduction of Fertilizer -- 4.5 Relevant Stakeholders in the Implementation of Policy -- 4.6 Report of Nanobiofertilizers Worldwide -- 4.7 Government Agencies and Their Impact -- 4.8 Translating Research Into Policy -- 4.9 Global Safety and Legal Framework for Agricultural Goods Based on Nanotechnology -- 4.10 Future Initiatives and Studies to Support the Development of Nanobiofertilizers -- Conclusion -- References -- Chapter 5 Structural Elucidation, Detection, and Characterization of Essential Nutrients Necessary for Soil Fertilization -- 5.1 Introduction -- 5.1.1 Importance of Soil Fertility in Agriculture -- 5.1.2 Role of Essential Nutrients in Soil Fertilization -- 5.2 Nitrogen (N) in Soil Fertilization -- 5.2.1 Significance of Nitrogen for Plant Growth -- 5.2.2 Structural Elucidation of Nitrogen Compounds -- 5.3 Phosphorus (P) in Soil Fertilization -- 5.3.1 Importance of Phosphorus in Plant Growth -- 5.3.2 Structural Elucidation of Phosphorus Compounds -- 5.4 Potassium (K) in Soil Fertilization -- 5.4.1 Role of Potassium in Plant Nutrition -- 5.4.2 Characterization of Potassium in Soils -- 5.5 Optimization of Nutrient Management Strategies -- 5.5.1 Integration of Nutrient Detection and Characterization Data -- 5.5.2 Targeted and Efficient Fertilization Approaches -- Conclusion -- References -- Chapter 6 Effect of Nanobiofertilizer on Phytochemicals -- 6.1 General Overview on Nanobiofertilizer -- 6.2 Constituents of Nanobiofertilizer -- 6.2.1 Nanoparticles -- 6.2.1.1 Zinc Nanoparticles or ZnNPs -- 6.2.1.2 Silver Nanoparticles or AgNPS -- 6.2.1.3 Silicon Nanoparticles or SiNPs -- 6.2.1.4 Copper Nanoparticles or CuNPs -- 6.2.2 Biofertilizer -- 6.2.3 Preparation of Nanobiofertilizer -- 6.2 Concept of Nanobiofertilizers and Their Potential as a Sustainable Alternative to Conventional Fertilizers.
6.3 Importance of Phytochemicals in Plant Growth and Human Health -- 6.3.1 Phytochemical Research -- 6.4 Mechanisms of Nanobiofertilizer on Phytochemicals -- 6.4.1 Mechanism of Action of NFs -- 6.4.2 Mode of Application of NFs -- 6.4.3 Roots -- 6.5 Recent Studies on Effect of Nanobiofertilizer on Phytochemicals -- 6.6 Conclusion and Future Trends on Nanobiofertilizer on Phytochemicals -- References -- Chapter 7 Characterization of Nanoparticles Used as Nanobiofertilizers -- 7.1 Introduction -- 7.2 Some Spectroscopic Characterization Technique for Nanomaterials -- 7.2.1 X-Ray Diffraction (XRD) -- 7.2.2 Principle of X-Ray Diffraction (XRD) -- 7.2.3 Ultraviolet-Visible Spectroscopy (UV-vis) -- 7.2.4 Scanning Electron Microscopy (SEM) -- 7.2.5 Zeta Potential Measurements (ZPM) -- 7.2.6 Principle of Zeta Potential Measurements (ZPM) -- 7.2.7 Dital Polarimeter -- 7.2.8 Dynamic Light Scattering (DSL) -- 7.2.8.1 Principle of Dynamic Light Scattering (DSL) -- 7.2.9 Transform Infrared (FTIR) Spectroscopy -- 7.2.9.1 Principle of Transform Infrared (FTIR) Spectroscopy -- 7.3 Characterization of Nanobiofertilizer Through Chemical and Biological Synthesis -- 7.4 Application of Nanobiofertilizer -- 7.5 Environmental Impact Assessment -- 7.6 Future Perspectives and Challenges -- 7.6.1 Future Perspectives -- 7.6.2 Challenges -- 7.7 Conclusion -- References -- Chapter 8 Toxicological Effects of Nanobiofertilizer on Water Body, Water Quality, Lower Plants, Zooplanktons, and Beneficial Microorganisms -- 8.1 Introduction -- 8.2 Effects of Nanofertilizer on Soil Microbial Community -- 8.3 Nanofertilizers Versus Biofertilizers: Dissimilarity in Synthesis -- 8.4 Nanobiofertilizer -- 8.4.1 Toxicological Effects of Nanobiofertilizer on Water Body and Water Quality -- 8.4.2 Effects of Nanobiofertilizer on Lower Plants -- 8.4.3 Effects of Nanobiofertilizer on Zooplanktons.
8.4.4 Toxicological Effects of Nanobiofertilizer on Beneficial Microorganisms -- 8.5 Conclusion -- References -- Chapter 9 Various Techniques Used in the Application of Nanobiofertilizers on Crops After Synthesis -- 9.1 Introduction -- 9.2 Synthesis of Nanoparticles -- 9.2.1 Microbial Synthesis of Nanomaterials -- 9.2.2 Plant-Mediated Synthesis of Nanoparticles -- 9.3 Synthesis of Nanobiofertilizers -- 9.4 Methods Used in the Application of Nanobiofertilizers on Crops -- 9.4.1 Foliar Spraying -- 9.4.2 Seed Nanopriming -- 9.4.3 Soil Treatment -- 9.5 Conclusion -- References -- Chapter 10 Non-Target Effect, Environmental Impact, and Assessment of Nanobiofertilizer -- 10.1 Introduction -- 10.2 Environmental Impact of Nanobiofertilizer on Soil Properties -- 10.3 Non-Targeted Effects on Soil Properties -- 10.3.1 Physicochemical Properties of Soil -- 10.3.2 Biological Properties of Soil -- Soil Carbon and Carbon Sequestration -- Soil Respiration -- Soil Enzymes -- Soil Microorganisms and Microbial Diversity -- 10.4 Recommendation and Conclusion -- References -- Chapter 11 Reported Genes Regulating the Biological Activities in Microorganisms Used in the Formation of Nanobiofertilizers -- 11.1 Introduction -- 11.2 Synthesis of Nanoparticles -- 11.2.1 Biosynthesis of Nanoparticles -- 11.2.2 Microorganisms Used for the Synthesis of Nanobiofertilizers -- 11.3 Genes Regulating the Biological Activities in Plant Growth-Promoting Rhizobacteria -- 11.4 Conclusion -- References -- Chapter 12 Relevance of Molecular Genetics and Synthetic Biology Involved in the Characterization of Microorganisms Used in Nanofertilizer Research -- 12.1 Introduction -- 12.2 Molecular Genetics and Synthetic Biology -- 12.2.1 Molecular Genetics -- 12.2.2 Synthetic Biology -- 12.2.2.1 Synthetic Biology Tools for Engineering Nanobiofertilizer Microorganisms.
12.2.2.2 Case Studies on Use of Synthetic Biology to Enhance Microorganisms for Nanobiofertilizers.
Record Nr. UNINA-9910902900303321
Adetunji Charles Oluwaseun  
Newark : , : John Wiley & Sons, Incorporated, , 2024
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Medicinal Plants, Phytomedicines and Traditional Herbal Remedies for Drug Discovery and Development Against COVID-19
Medicinal Plants, Phytomedicines and Traditional Herbal Remedies for Drug Discovery and Development Against COVID-19
Autore Rudrapal Mithun
Edizione [1st ed.]
Pubbl/distr/stampa Sharjah : , : Bentham Science Publishers, , 2023
Descrizione fisica 1 online resource (254 pages)
Disciplina 615.321
Altri autori (Persone) EgbunaChukwuebuka
Soggetto topico Medicinal plants
Alternative medicine
ISBN 9789815049510
9815049518
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- Phytoconstituents from Mother Nature against SARS-CoV-2/ COVID-19 -- Neelesh Kumar Nema1,*, Swapnil Devidas Khamborkar1, Smitha Sarojam1, Baby Kumaranthara Chacko1 and Viju Jacob1 -- INTRODUCTION -- MATERIALS AND METHODS -- SARS-CoV-2 and Phytoconstituents Data Collection -- Information Evaluation -- RESULTS -- SARS-CoV-2 and Ethnomedicinal Plants -- SARS-CoV-2 Morphological Features and Structure -- SARS-CoV-2 Replication in the Host Cells -- Interactions with the Host Cell -- Fusion of Genomes -- Replication (Transcription and Translation) -- Exit from the Host Cell -- Targets for Therapeutic Intervention -- Pre-Viral Infection Targeted Approaches -- Post-Viral Infection Targeted Approaches -- SARS-COV-2 REPLICATION -- Immunomodulatory Targets -- Solutions for the Treatment -- Medicinal Plants from Mother Nature -- Andrographis paniculata -- Azadirachta indica -- Cinnamomum verum -- Clerodendrum serratum -- Curcuma longa -- Cymbopogon jwarancusa -- Glycyrrhiza glabra -- Hedychium spicatum -- Inula racemosa -- Justicia adhatoda -- Illicium verum -- Ocimum basilicum & -- Ocimum tenuiflorum -- Phyllanthus emblica -- Pichrorhiza kurroa -- Swertia chirata -- Syzygium aromaticum -- Tinospora cordifolia -- Withania somnifera -- Zingiber afficinale -- DISCUSSION -- CONCLUSION -- ABBREVIATIONS -- REFERENCES -- Role of Medicinal Plants and Phytomedicine against COVID-19 Management -- Kunika Saini1, Smriti Sharma1,* and Vinayak Bhatia2 -- INTRODUCTION -- TRANSMISSION AND LIFE CYCLE OF SARS-COV-2 -- LIFE CYCLE OF SARS-COV-2 -- DRUG DISCOVERY STRATEGIES AGAINST SARS-COV-2 INFECTION -- An Outline of COVID-19 Therapeutics and Drugs -- Drug Design Strategies against COVID-19 -- ROLE OF PHYTOMEDICINE IN TREATING SARS-COV-2 INFECTION.
Phytomedicine: The Gold Mine for Designing Novel Drugs -- The Potential of Medicinal Plants for Treating COVID-19 -- Ayurvedic Approaches -- Unani Approaches -- Siddha Approaches -- MEDICINAL PLANTS FOR TREATING COVID-19: CURRENT STATUS -- CONCLUSION AND FUTURE PERSPECTIVES -- REFERENCES -- Immune Foods for Fighting Coronavirus Disease-2019 (COVID-19) -- Chinaza Godswill Awuchi1,2,3,*, Hannington Twinomuhwezi2,4, Chibueze Gospel Awuchi5, Ikechukwu O. Amagwuala3 and Chukwuebuka Egbuna6,7,8 -- INTRODUCTION -- ROLE OF FOODS CONSTITUENTS IN IMMUNE SYSTEM FUNCTIONS -- Macronutrients and Their Immune Functions -- Micronutrients and Their Immune Functions -- FOOD COMPONENTS, NUTRIENTS, AND COVID-19 -- IMMUNE BOOSTING MICRONUTRIENTS AGAINST COVID-19 (SARS-COV-2) -- Vitamins for Fighting COVID-19 -- Minerals for Fighting COVID-19 -- ACTIONS OF BIOACTIVE COMPOUNDS IN FOODS AGAINST COVID-19 (SARS-COV-2) -- FOOD, OBESITY, IMMUNITY, AND COVID-19 -- CONCLUSION -- REFERENCES -- Plant Sources of Pro and Anti-Inflammatory Mediators against COVID-19 -- Iqra Yasmin1,*, Wahab A. Khan2, Ayesha Manzoor3, Muhammad W. Iqbal4 and Muhammad Azam5 -- INTRODUCTION -- Pro-Inflammatory and Anti-Inflammatory Mediators from Fruits and Vegetables -- Health Benefits -- In Vitro and In Vivo Studies of Fruits and Vegetables against Inflammation -- Pro-Inflammatory and Anti-Inflammatory Mediators from Legumes -- CONCLUSION -- REFERENCES -- Drug Therapies against Acute Respiratory Distress: A Critical Endpoint of COVID-19 -- Maha M. Salama1,2, Rana M. Merghany3, Ahmed Zayed4, Mohamed A. Salem5 and Shahira M. Ezzat1,6,* -- INTRODUCTION -- CHARACTERISTICS OF HUMAN CORONAVIRUSES AND SARS-COV- 2 -- CONTRIBUTION OF THE INFLAMMATORY PATHWAYS TO THE PATHOGENESIS OF ACUTE RESPIRATORY DISTRESS AND COVID-19 -- CURRENT MANAGEMENT OF COVID-19.
Antiviral Drugs Approved/Under Assessment for the Treatment of COVID-19 -- Antithrombotic Therapy in Patients COVID-19 (with Anticoagulants and/or Antiplatelet Drugs) -- Anti-Coagulant Therapy -- Anti-Platelet Therapy -- Cell-Based Therapy for the Treatment of COVID-19 (Under Assessment) -- Reported Clinical Trials on Mesenchymal Cells for COVID-19 -- Immunomodulatory/Anti-cytokine Therapies -- Convalescent Plasma -- Anti-Cytokine Therapies -- Intravenous Immunoglobulin Therapy -- Anti-Inflammatory Therapy -- Corticosteroids -- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) -- Herbal Medicines Alleviating Acute Respiratory Infection -- i. Echinacea purpurea -- ii. Portulaca oleracea -- iii. Eucalyptus globulus -- iv. Glycyrrhiza glabra -- v. Curcuma longa -- vi. Thymus vulgaris -- vii. Taraxacum sp. -- viii. Ginkgo biloba -- ix. Radix bupleuri -- HERBAL-DERIVED NATURAL PRODUCTS IN BOOSTING THE BODY'S IMMUNITY -- CONCLUSION -- REFERENCES -- Medicinal Spices for the Prevention and Treatment of Coronavirus Disease-2019 -- Muhammad Akram1,*, Rabia Anum2, Walaa Fikry Elbossaty3, Chukwuebuka Egbuna4,5,6, Chinaza Godswill Awuchi7,8,9, Chukwuemelie Zedech Uche10, Kingsley C. Patrick-Iwuanyanwu4,5, Soumya Bhattacharya11 and Mithun Rudrapal12 -- INTRODUCTION -- Medicinal Plant Spices and Herbs for COVID-19 -- Ginger -- Garlic -- Fenugreek -- Black Pepper -- Clove -- Red Chilli Peppers -- Curcumin -- Nigella Sativa -- Fennel -- Onion -- Nutmeg -- Cinnamon -- Cinnamomum Tamala -- Cardamum -- Ajwain -- Moringa Oleifera Lam -- CONCLUSION -- REFERENCES -- Boosting Host Immunity to Combat Coronavirus Disease-2019 (COVID-19) -- Mithun Rudrapal1,*, Soumya Bhattacharya2 and Dipak Chetia3 -- INTRODUCTION -- CURRENT THERAPEUTIC AND PROPHYLACTIC INTERVENTIONS -- IMMUNE INFLAMMATORY RESPONSES TO SARS-COV-2 INFECTION.
BOOSTING HOST IMMUNITY: DIETARY, HERBAL AND ALTERNATIVE APPROACHES -- Diet and Foods -- Natural Foods -- Fruits and Vegetables -- Food Spices -- Herbs and Herbal Drugs -- Immunomodulatory Herbs -- Antiviral Herbs -- Herbs with Other Healing Properties -- Yoga and Naturopathy -- CONCLUSION -- REFERENCES -- Functional Foods, Herbal Supplements and Nutraceuticals in the Management of Coronavirus Disease-2019 (COVID-19) -- Santwana Palai1,* and Mithun Rudrapal2 -- INTRODUCTION -- EPIDEMIOLOGY OF COVID-19 -- DIETARY IMMUNOMODULATORS IN COVID-19 MANAGEMENT -- FUNCTIONAL FOODS, HERBAL SUPPLEMENTS AND NUTRACEUTICALS IN DISEASES MANAGEMENT -- BENEFICIAL EFFECTS OF ANTIVIRAL/IMMUNOMODULATORY FUNCTIONAL FOOD IN THE MANAGEMENT OF COVID-19 -- BENEFICIAL EFFECTS OF HERBAL SUPPLEMENTS/ PHYTOCONSTITUENTS/ NUTRACEUTICALS FOR RESPIRATORY AILMENTS/ INFECTIONS IN THE MANAGEMENT OF COVID-19 -- BENEFICIAL EFFECTS OF IMMUNOMODULATING NUTRACEUTICALS IN MANAGEMENT OF COVID-19 -- FUTURE PERCEPTIVE -- CONCLUSION -- ABBREVIATIONS -- REFERENCES -- Aromatic Plants, Essential oils, Carminatives, Tea Plants and Expectorant Herbs for the Management of COVID-19 -- Sonal Upadhyay1, Ravi Bhushan1, Pawan Kumar Dubey1, Bashir A Sheikh2, Mithun Rudrapal3,* and James H. Zothantluanga4 -- INTRODUCTION -- AROMATIC PLANTS IN THE MANAGEMENT OF COVID-19 -- Ginger -- Clove -- Curcumin -- ESSENTIAL OILS IN THE MANAGEMENT OF COVID-19 -- Eucalyptus Oil -- Garlic Oil -- Eugenol, Menthol and Carvacrol -- CARMINATIVES AND SPICE IN THE MANAGEMENT OF COVID-19 -- Long Pepper -- Turmeric -- Fenugreek -- TEA PLANTS/ HERBAL TEA IN THE MANAGEMENT OF COVID-19 -- EXPECTORANT HERBS IN THE MANAGEMENT OF COVID-19 -- Eucalyptus globulus -- Hedera helix -- Justicia pectoralis -- CONCLUSION -- REFERENCES -- Subject Index -- Back Cover.
Record Nr. UNINA-9911008986803321
Rudrapal Mithun  
Sharjah : , : Bentham Science Publishers, , 2023
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Mushroom Biotechnology for Improved Agriculture and Human Health
Mushroom Biotechnology for Improved Agriculture and Human Health
Autore Adetunji Charles Oluwaseun
Edizione [1st ed.]
Pubbl/distr/stampa Newark : , : John Wiley & Sons, Incorporated, , 2025
Descrizione fisica 1 online resource (397 pages)
Altri autori (Persone) EgbunaChukwuebuka
IjabadeniyiOluwatosin Ademola
KarunarathnaSamantha C
ISBN 9781394212675
1394212674
9781394212699
1394212690
9781394212682
1394212682
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Series Page -- Title Page -- Copyright page -- Contents -- Preface -- Chapter 1 Application of Mushrooms in the Bioremediation of Environmental Pollutants -- Introduction -- Unique Characteristics of Fungi -- Specific Contaminants Targeted by Mushrooms -- Mechanisms of Mushroom Bioremediation -- Absorption and Accumulation of Contaminants by Mushrooms -- Transformation and Degradation of Pollutants -- Role of Enzymes and Metabolic Processes -- Advancements and Research in Mushroom Bioremediation -- Emerging Trends in Fungal Bioremediation -- Genetic Modification of Mushrooms for Enhanced Bioremediation -- Benefits of Mushroom Bioremediation -- Challenges and Limitations of Using Mushrooms -- Future Prospects and Research Opportunities -- Conclusion and Recommendations -- References -- Chapter 2 Application of Mushroom in the Management of Pest and Diseases Affecting Agricultural Crops -- 2.1 Introduction -- 2.2 Properties of Mushroom as Biocontrol Agents (Basidiomycetes) -- 2.3 Mushroom Substrate as Biocontrol Agent for Plant -- 2.4 Mechanism of Action of Mushrooms in the Control of Pests and Diseases -- 2.5 Several Areas Where Mushrooms Can Be Applied -- 2.6 Mushrooms as Disease Control Agents -- 2.7 Conclusion -- References -- Chapter 3 Agricultural Applications of Novel Mushroom-Based Nanopesticide -- 3.1 Introduction -- 3.2 Advantages of Nanobiopesticides Over Conventional Pesticides -- 3.3 Mushrooms as Nanobiopesticide Sources -- 3.4 Bioactive Compounds in Mushrooms Suitable for Nanobiopesticide Development -- 3.5 Role of Mushroom Extracts in Nanoparticle Synthesis -- 3.6 Mechanisms of Action of Nanobiopesticides on Pests and Pathogens -- 3.7 Production and Formulation of Nanobiopesticides -- 3.8 Agricultural Applications of Nanobiopesticides -- 3.9 Future Prospects and Research Directions -- 3.10 Recommendation and Conclusion.
References -- Chapter 4 Mass Production of Mushroom for Animal Feed -- 4.1 Introduction -- 4.2 Mushroom -- 4.3 Mushroom Production -- 4.3.1 Mass Production of Mushrooms for Animal Feed -- 4.3.2 Mushroom Substrate (Spent) for Feed -- 4.3.3 Mushroom Substrate (Spent) for Poultry -- 4.3.4 Mushroom Substrate (Spent) for Ruminants -- 4.4 Benefits of Feeding Animals with Mushrooms -- 4.5 Conclusion -- References -- Chapter 5 Application of Mushrooms in Management of Soil-Borne Parasites, Nematodes, Bacteria and Fungi -- 5.1 Introduction -- 5.2 Soil-Borne Parasites, Nematodes, Bacteria, and Fungi -- 5.2.1 Soil-Borne Nematodes -- 5.2.2 Types of Soil-Borne Bacteria -- 5.2.3 Types of Soil-Borne Fungi -- 5.3 Mushrooms as Biocontrol Agents -- 5.3.1 Mushrooms as Natural Biopesticide -- 5.3.2 Mechanisms of Mushroom-Mediated Biocontrol -- 5.4 Mushroom Species and Biocontrol Potential -- 5.5 Advantages of Mushroom Biocontrol -- 5.6 Challenges and Limitations of Mushroom Bio-Control -- 5.7 Conclusion and Future Outlook -- References -- Chapter 6 Production of Stable Enzymes from Mushrooms with Numerous Biomedical Applications -- 6.1 Introduction -- 6.2 Classes/Types of Mushrooms -- 6.2.1 Button Mushroom (Agaricus bisporus) -- 6.2.2 Oyster (Pleurotus ostreatus) -- 6.2.3 Portabello -- 6.2.4 Morel (Morchella) -- 6.2.5 Reishi (Ganoderma lucidum) -- 6.2.6 Burnt Matches (Eutypellascorpia) -- 6.2.7 Chanterelle (Cantharellus) -- 6.2.8 Laetiporus sulphureus -- 6.2.9 Cordyceps (Cordyceps militaris) -- 6.2.10 Enokitake (Flammulina velutipes) -- 6.2.11 Giraffe Spots (Endophora albobadia) -- 6.2.12 Destroying Angel (Amanita sp.) -- 6.2.13 Green-Spored Lepiota (Chloropyhllum) -- 6.2.14 Matsutake Mushroom -- 6.2.15 Shiitake Mushroom (Lentinula edodes) -- 6.2.16 Truffles -- 6.2.17 Shimeji -- 6.3 Stable Enzymes Produced by Mushrooms -- 6.3.1 Ligninolytic Enzymes.
6.3.1.1 Lignin Peroxidase -- 6.3.1.2 Manganese Peroxidase -- 6.3.1.3 Versatile Peroxidase -- 6.3.1.4 Laccases -- 6.3.1.5 Tyrosinase -- 6.3.2 Hydrolases -- 6.3.2.1 Cellulases -- 6.3.2.2 Xylanase -- 6.3.2.3 Pectinases -- 6.3.2.4 Amylases -- 6.3.2.5 Proteases -- 6.3.2.6 Esterase -- 6.3.3 Stress Enzymes -- 6.4 Biomedical and Biotechnological Applications of Stable Mushroom Enzymes -- 6.4.1 Mushroom Enzymes as Antimicrobial Agents -- 6.4.2 Mushroom Enzymes as Anticancer and Antitumor Agents -- 6.4.3 Mushroom Enzymes as Antioxidants -- 6.4.4 Other Applications of Mushroom Enzymes -- 6.5 Some Limitations of Mushroom Enzymes -- 6.6 Conclusion and Future Perspectives -- References -- Chapter 7 Relevance of Mushrooms for Biological Control of Diverse Biotic Agent Mitigating Against Agricultural Crops -- 7.1 Introduction -- 7.1.1 Benefits of Using Mushrooms in Pest and Disease Management -- 7.1.2 Challenges of Mycopesticides -- 7.2 Fungal Biopesticides -- 7.2.1 How Fungal Biopesticides Work -- 7.2.2 Advantages of Fungal Biopesticides -- 7.2.3 Challenges and Considerations of Fungal Biopesticides -- 7.2.4 Some Key Points Regarding Fungal Biopesticides -- 7.3 Mycoparasitism -- 7.4 Nutrient Cycling and Soil Health -- 7.5 Companion Planting -- 7.6 Challenges and Considerations -- 7.7 Conclusion and Future Perspectives -- 7.7.1 Future Perspectives -- References -- Chapter 8 Discovery and Relevance of Novel Pharmacological Substances from Beneficial Mushrooms -- 8.1 Introduction -- 8.1.1 Brief Overview of Beneficial Mushrooms -- 8.1.2 Importance of Discovering Novel Pharmacological Substances in Mushrooms -- 8.1.3 Beneficial Mushrooms as a Source of Pharmacological Substances -- 8.1.4 Historical Use of Mushrooms in Traditional Medicine -- 8.2 Bioactive Compounds in Mushrooms -- 8.3 Pharmacological Activities of Mushroom-Derived Compounds.
8.4 Clinical Applications and Relevance -- 8.5 Challenges and Future Directions -- Conclusion -- References -- Chapter 9 Application of Mushroom in the Management of Diabetes Mellitus -- Introduction -- Pathophysiology of Diabetes Mellitus -- Mushroom and Its Biomolecules -- Mushroom and Health -- Therapeutic Potential of Mushroom in the Management of Diabetes Mellitus -- Conclusion -- References -- Chapter 10 Application of Mushrooms in the Management of Cardiovascular Diseases -- 10.1 Introduction -- 10.2 Selected Medicinal Mushrooms -- 10.2.1 Ganoderma lucidum -- 10.2.2 Hericium erinaceus (Lions Mane Mushroom) -- 10.2.3 Agaricus bisporus -- 10.3 Nutritional Composition of Mushrooms -- 10.4 Bioactive Compounds in Mushrooms -- 10.4.1 The Polysaccharide -- 10.4.2 Terpenoids -- 10.4.3 Steroids -- 10.4.4 Phenolics -- 10.4.5 Alkaloids -- 10.5 Cardioprotective Effect of Mushrooms -- 10.6 Conclusion -- References -- Chapter 11 Application of Mushroom in the Regulation of Gut Microbiome and Maintenance of Gut Health -- Introduction -- Gut Microbiome in Health and Disease -- Mushrooms and Their Derived Bioactive Molecules -- Health Benefits of Edible Mushroom Associated with Maintenance of Gut Health -- Conclusion -- References -- Chapter 12 Applications of Mushrooms in the Management of Cancers -- 12.1 Introduction -- 12.2 Cancer -- 12.2.1 Types of Cancer -- 12.3 Mushrooms -- 12.3.1 Major Bioactive Compounds in Medicinal Mushroom -- 12.3.1.1 Metabolites with a Substantial Molecular Weight -- 12.3.1.2 Metabolites with a Low Molecular Weight -- 12.3.1.3 Polyphenolic Compounds (Styrylpyrone-Class of Phenols) -- 12.3.2 Mechanisms by Which Certain Mushrooms Exhibit Anti-Cancer Effects -- 12.3.2.1 Immune Modulation -- 12.3.2.2 Angiogenesis -- 12.3.2.3 DNA Repair Inhibition -- 12.3.2.4 Apoptosis -- 12.3.2.5 Metastasis.
12.3.3 Some Mushrooms and Their Anti-Cancer Properties -- 12.3.3.1 Agaricus bisporus -- 12.3.3.2 Antrodia cinnamomea -- 12.3.3.3 Cordyceps sinensis -- 12.3.3.4 Coriolus versicolor -- 12.3.3.5 Ganoderma lucidum -- 12.3.3.6 Grifola frondosa (Maitake) -- 12.3.3.7 Lentinula edodes (Shitake) -- 12.3.3.8 Pleurotus ostreatus (Jacq.) -- 12.3.4 Exploring Novel Mushroom-Derived Therapies for Cancer -- 12.3.4.1 Vaccinotherapy -- 12.3.4.2 Nanovectors for Drug Delivery -- 12.4 Conclusion -- References -- Chapter 13 Applications of Mushrooms as Immune Boosters -- 13.1 Introduction -- 13.2 Mushroom Composites -- 13.3 ß-Glucans and Their Nutritional Components -- 13.4 Antiproliferative and Other Human Health Reactions of Medicinal Mushrooms -- Conclusion -- References -- Chapter 14 The Influence of Mushroom on the Taphonomic Process of Cadaver -- 14.1 Introduction -- 14.2 Mushroom and the Fungus Phylogeny -- 14.3 Mushroom Taphonomic Process -- 14.4 Influence of Mushroom on Cadaver Taphonomy -- 14.5 Conclusion -- References -- Chapter 15 Role of Nanobiopesticides Derived from Mushrooms: Recent Advances -- 15.1 Introduction -- 15.2 Environmental and Health Concerns with Chemical Pesticides -- 15.3 Mushrooms as a Source of Bioactive Compounds -- 15.4 Antimicrobial and Insecticidal Properties of Mushrooms -- 15.4.1 Antimicrobial Properties -- 15.4.2 Antiparasitic Activity -- 15.5 Nanotechnology and its Applications in Agriculture -- 15.6 Mechanisms of Action of Nanobiopesticides -- 15.7 Benefits and Advantages of Nanobiopesticides -- 15.8 Conclusion and Future Perspectives -- 15.8.1 Conclusion -- 15.8.2 Future Perspectives -- References -- Chapter 16 Nutraceutical, Mineral, Proximate Constituents from Beneficial Mushrooms -- 16.1 Introduction -- 16.2 Nutraceutical Constituents of Mushrooms -- 16.3 Mineral Constituents of Mushrooms.
16.4 Proximate Constituents of Mushrooms.
Record Nr. UNINA-9910988180403321
Adetunji Charles Oluwaseun  
Newark : , : John Wiley & Sons, Incorporated, , 2025
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Neglected tropical diseases and phytochemicals in drug discovery / / edited by Chukwuebuka Egbuna, Muhammad Akram, Jonathan Chinenye Ifemeje
Neglected tropical diseases and phytochemicals in drug discovery / / edited by Chukwuebuka Egbuna, Muhammad Akram, Jonathan Chinenye Ifemeje
Pubbl/distr/stampa Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2022]
Descrizione fisica 1 online resource (624 pages)
Disciplina 616.9883
Soggetto topico Tropical medicine
Phytochemicals - Therapeutic use
Soggetto genere / forma Electronic books.
ISBN 1-119-61715-4
1-119-61714-6
1-119-61711-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Preface -- Part I Introduction to Neglected Tropical Diseases -- Chapter 1 Epidemiology of Neglected Tropical Diseases -- List of Abbreviations -- 1.1 Introduction -- 1.2 Protozoan Infections -- 1.2.1 Human African Trypanosomiasis -- 1.2.2 Chagas Disease (American Trypanosomiasis) -- 1.2.3 Leishmaniasis -- 1.2.4 Amoebiasis -- 1.3 Helminth Infections -- 1.3.1 Soil-Transmitted Helminthiasis Infections -- 1.3.2 Schistosomiasis -- 1.3.3 Echinococcosis -- 1.3.4 Lymphatic Filariasis -- 1.3.5 Onchocerciasis ("River Blindness") -- 1.3.6 Foodborne Trematodiases -- 1.3.7 Dracunculiasis (Also Called Guinea Worm Disease) -- 1.4 Bacterial Infections -- 1.4.1 Yaws -- 1.4.2 Trachoma -- 1.4.3 Leprosy -- 1.4.4 Buruli Ulcer -- 1.5 Viral Infections -- 1.5.1 Rabies -- 1.5.2 Dengue -- 1.5.3 Chikungunya -- 1.6 Fungal and Ectoparasitic Infections -- 1.6.1 Chromoblastomycosis, Mycetoma/Eumycetoma, and Other Deep Mycoses -- 1.6.2 Scabies -- 1.6.3 Myiasis -- 1.7 Future Direction -- 1.8 Conclusion -- Acknowledgments -- References -- Chapter 2 Neglected Tropical Diseases, Phytochemicals, Protein Targets, and Mechanisms in Drug Discovery -- List of Abbreviations -- 2.1 Introduction -- 2.2 African Trypanosomiasis -- 2.2.1 Phytochemicals Against African Trypanosomiasis -- 2.3 Buruli Ulcer -- 2.3.1 Phytochemicals Against Buruli Ulcer -- 2.4 Chagas Disease -- 2.4.1 Phytochemicals Against Chagas Disease -- 2.5 Chikungunya -- 2.5.1 Phytochemicals Against Chikungunya -- 2.6 Dengue -- 2.6.1 Phytochemicals Against Dengue -- 2.7 Leishmaniasis -- 2.7.1 Phytochemicals Against Leishmaniasis -- 2.8 Leprosy -- 2.8.1 Indeterminate Leprosy -- 2.8.2 Phytochemicals Against Leprosy -- 2.9 Lymphatic Filariasis -- 2.9.1 Phytochemicals Against Lymphatic Filariasis -- 2.10 Mycetoma -- 2.10.1 Phytochemicals Against Mycetoma.
2.11 Onchocerciasis -- 2.11.1 Phytochemicals Against Onchocerciasis -- 2.12 Rabies -- 2.12.1 Phytochemicals Against Rabies -- 2.13 Scabies -- 2.13.1 Phytochemicals Against Scabies -- 2.14 Schistosomiasis -- 2.14.1 Phytochemicals Against Schistosomiasis -- 2.15 Conclusion -- References -- Chapter 3 Novel Bioactive Lead Compounds for Drug Discovery Against Neglected Tropical Diseases, Leishmaniasis, Lymphatic Filariasis, Trypanosomiasis (African Sleeping Sickness and Chagas Disease), and Schistosomiasis -- List of Abbreviations/Definitions -- 3.1 Introduction -- 3.2 Prevalence of Neglected Tropical Diseases -- 3.2.1 Leishmaniasis -- 3.2.2 Lymphatic Filariasis -- 3.2.3 Trypanosomiasis -- 3.2.3.1 African Trypanosomiasis (African Sleeping Sickness) -- 3.2.3.2 American Trypanosomiasis (Chagas Disease) -- 3.2.4 Schistosomiasis -- 3.3 Novel, Economical, and Efficacious Therapeutics from Medicinal Plants Against NTDs -- 3.3.1 Phytochemicals Effective Against Leishmania Parasite -- 3.3.2 Plants and Phytochemicals Effective Against Filarial Parasite -- 3.3.3 Plants and Phytochemicals Effective Against Trypanosomasis -- 3.3.4 Plants and Phytochemicals Effective Against Schistosomiasis -- 3.4 Future Prospects -- 3.5 Conclusion -- References -- Part II Protozoan Infections -- Chapter 4 Herbal, Nutritional, and Traditional Remedies for Giardiasis: Phytochemicals as Drug Candidates -- List of Abbreviations -- 4.1 Introduction -- 4.1.1 Epidemiology and Symptoms of Giardiasis -- 4.1.2 Life Cycle of G. duodenalis -- 4.1.3 Pathophysiology of Giardial Infection -- 4.1.4 Resistance to Allopathic Drug and Relevance of Herbal Medication -- 4.2 Plant-Based Dietary Supplements for Giardiasis Management -- 4.2.1 Oligosaccharide and Disaccharidase Supplementation -- 4.2.2 Dietary Fiber-Enriched Food -- 4.2.3 Agglutinin from Wheat -- 4.2.4 Vitamin and Mineral Supplements.
4.2.4.1 Vitamin A Supplementation -- 4.2.4.2 Compensation of Vitamin B12 -- 4.2.4.3 Zinc Status Management -- 4.2.5 Fermented Vegetables as Probiotic Source -- 4.2.6 Phenolic Compound Enriched Plant Food -- 4.3 Traditional Treatment of Giardiasis with Herbal Ethnomedicine -- 4.3.1 Hints of Antiprotozoal Medicines from Ancient Communities -- 4.3.2 Domestic Remedies and Alternative Medicine for Giardiasis -- 4.3.3 Applied Spectrum of Ethnopharmacology in Different Continents -- 4.3.3.1 Asian Medicinal Extracts -- 4.3.3.2 African Traditional Medicines -- 4.3.3.3 South American Ethnomedicine -- 4.4 Phytochemical Candidates for Advanced Giardicidal Drug Development -- 4.4.1 Terpenoids -- 4.4.2 Aromatic Ether -- 4.4.3 Alkaloids -- 4.4.4 Organo-sulfur Compounds -- 4.4.5 Lipids and Steroids -- 4.4.6 Phenolic Compounds -- 4.5 Future Prospects -- 4.5.1 Extension of Medicinal Compound Screening -- 4.5.2 Methodical Studies on Toxicology and Drug Adversity -- 4.5.3 Correlation of Herbal Drugs with Molecular Targets of Giardia -- 4.6 Summary, Prospects, and Conclusion -- References -- Chapter 5 Antiprotozoal Activity of Phytochemicals Against Entamoeba histolytica, the Causative Agent of Amoebiasis -- List of Abbreviations -- 5.1 Introduction -- 5.2 Life Cycle of Entamoeba histolytica -- 5.3 Diagnostic Techniques for Identification of E. histolytica -- 5.3.1 Intestinal Amoebiasis -- 5.3.1.1 Microscopy -- 5.3.1.2 Culture and Isoenzyme Analysis -- 5.3.1.3 Antigen Detection Test -- 5.3.1.4 Molecular-Based Test -- 5.3.1.5 Point-of-Care (POC) Test -- 5.4 Treatment of Amoebiasis -- 5.5 Alternative Treatment for Amoebiasis -- 5.6 Chemical Structure of Phytochemicals Effective Against E. histolytica -- 5.7 Possible Mechanisms of Phytochemicals as Antiamoebic -- 5.8 Future Projections -- 5.9 Conclusion -- References -- Chapter 6 Antileishmanial Potentials of Phytochemicals.
6.1 Introduction -- 6.2 Antileishmanial Activity of Propolis -- 6.2.1 Propolis from Turkey -- 6.2.2 Propolis from Brazil -- 6.2.3 Propolis from Portugal -- 6.2.4 Propolis from Cuba -- 6.2.5 Propolis from Ecuador -- 6.3 Antileishmanial Activity of Wild Mushrooms -- 6.4 Antileishmanial Activity of Medicinal Plants from Various Flora -- 6.4.1 Peruvian Flora -- 6.4.2 Ecuadorean Flora -- 6.4.3 Mexican Flora -- 6.4.4 Bolivian Flora -- 6.4.5 Iranian Flora -- 6.5 Antileishmanial Activity of Chemical Constituents -- 6.5.1 Alkaloids -- 6.5.2 Flavonoids -- 6.5.3 Terpenes -- 6.5.4 Glycoglycerolipids -- 6.5.5 Guttiferone A as a Lead Compound for Semisynthesis of Antileishmanial Molecules -- 6.6 Conclusion -- References -- Part III Helminth Infections -- Chapter 7 Prospects of Phytochemicals for the Treatment of Helminthiasis -- List of Abbreviations -- 7.1 Introduction -- 7.1.1 History -- 7.1.2 Prevalence -- 7.2 Molecular Characteristics of Soil-transmitted Helminthiasis -- 7.3 Clinical Features and Pathogenesis -- 7.4 Prevention -- 7.5 Treatment -- 7.6 Plants and Phytochemicals with Anthelmintic Activities -- 7.6.1 Modes of Action of Phytochemical Against the Soil-transmitted Helminthiasis -- 7.7 Scientific Reports of Medicinal Plants with Anthelmintic Properties -- 7.7.1 Adhatoda vasica -- 7.7.2 Allium sativum -- 7.7.3 Baliospermum montanum Muell -- 7.7.4 Butea monosperma -- 7.7.5 Calotropis procera -- 7.7.6 Carica papaya -- 7.7.7 Ficus benghalensis -- 7.7.8 Mimosa pudica -- 7.7.9 Punica granatum -- 7.7.10 Verbascum thapsus -- 7.7.11 Zingiber officinale -- 7.8 Future Prospects -- 7.9 Conclusion -- References -- Chapter 8 Efficacy of Phytochemicals of Medicinal Plants for the Treatment of Human Echinococcosis: Echinococcal Disease, Hydatidosis, or Hydatid Disease Drug Discovery -- List of Abbreviations -- 8.1 Introduction -- 8.2 Molecular Analysis.
8.3 Life Cycle of Echinococcosis -- 8.4 Previous Studies on the Positive Effects of Medicinal Plants and Phytochemicals -- 8.4.1 In vitro and in vivo Effect of Phytochemicals Against Echinococcus Infection -- 8.5 Synthetic Drugs Previously Used for Management of Echinococcosis Disease -- 8.6 Conclusion and Future Prospects -- References -- Chapter 9 Filaricidal Activity of Phytochemicals Against Lymphatic Filariasis -- List of Abbreviations -- 9.1 Introduction -- 9.2 Life Cycle of the Parasite -- 9.3 Synthetic Drugs Used for Treatment of Lymphatic Filariasis -- 9.4 Phytochemicals Used for the Treatment of Lymphatic Filariasis -- 9.4.1 Acacia auriculiformis -- 9.4.2 Aegle marmelos -- 9.4.3 Alnus nepalensis -- 9.4.4 Andrographis paniculata -- 9.4.5 Azadirachta indica -- 9.4.6 Bauhinia racemosa -- 9.4.7 Butea monosperma -- 9.4.8 Caesalpinia bonducella -- 9.4.9 Cardiospermum halicacabum -- 9.4.10 Centratherum anthelminticum -- 9.4.11 Excoecaria agallocha -- 9.4.12 Ficus racemosa -- 9.4.13 Glycyrrhiza glabra -- 9.4.14 Hibiscus sabdariffa -- 9.4.15 Lantana camara -- 9.4.16 Leucas cephalotes -- 9.4.17 Mallotus philippensis -- 9.4.18 Morinda citrifolia -- 9.4.19 Moringa oleifera -- 9.4.20 Plumbago indica -- 9.4.21 Pongamia pinnata -- 9.4.22 Psoralea corylifolia -- 9.4.23 Ricinus communis -- 9.4.24 Saxifraga stracheyion -- 9.4.25 Sphaeranthus indicus -- 9.4.26 Streblus asper -- 9.4.27 Trachyspermum ammi -- 9.4.28 Vitex negundo -- 9.4.29 Xylocarpus granatum -- 9.4.30 Zingiber officinale -- 9.5 Future Perspective -- 9.6 Conclusion -- References -- Chapter 10 Dracunculiasis (Guinea Worm Disease) and Phytochemicals in Drug Discovery -- List of Abbreviations -- 10.1 Introduction -- 10.2 Historical Insights of Dracunculiasis -- 10.3 Prevalence, Burden, and Distribution of Disease -- 10.4 Life Cycle, Pathogenesis, and Clinical Manifestations of Dracunculiasis.
10.5 Prevention and Eradication of Disease.
Record Nr. UNINA-9910555163203321
Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2022]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Neglected tropical diseases and phytochemicals in drug discovery / / edited by Chukwuebuka Egbuna, Muhammad Akram, Jonathan Chinenye Ifemeje
Neglected tropical diseases and phytochemicals in drug discovery / / edited by Chukwuebuka Egbuna, Muhammad Akram, Jonathan Chinenye Ifemeje
Pubbl/distr/stampa Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2022]
Descrizione fisica 1 online resource (624 pages)
Disciplina 616.9883
Soggetto topico Tropical medicine
Phytochemicals - Therapeutic use
ISBN 1-119-61715-4
1-119-61714-6
1-119-61711-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Title Page -- Copyright Page -- Contents -- List of Contributors -- Preface -- Part I Introduction to Neglected Tropical Diseases -- Chapter 1 Epidemiology of Neglected Tropical Diseases -- List of Abbreviations -- 1.1 Introduction -- 1.2 Protozoan Infections -- 1.2.1 Human African Trypanosomiasis -- 1.2.2 Chagas Disease (American Trypanosomiasis) -- 1.2.3 Leishmaniasis -- 1.2.4 Amoebiasis -- 1.3 Helminth Infections -- 1.3.1 Soil-Transmitted Helminthiasis Infections -- 1.3.2 Schistosomiasis -- 1.3.3 Echinococcosis -- 1.3.4 Lymphatic Filariasis -- 1.3.5 Onchocerciasis ("River Blindness") -- 1.3.6 Foodborne Trematodiases -- 1.3.7 Dracunculiasis (Also Called Guinea Worm Disease) -- 1.4 Bacterial Infections -- 1.4.1 Yaws -- 1.4.2 Trachoma -- 1.4.3 Leprosy -- 1.4.4 Buruli Ulcer -- 1.5 Viral Infections -- 1.5.1 Rabies -- 1.5.2 Dengue -- 1.5.3 Chikungunya -- 1.6 Fungal and Ectoparasitic Infections -- 1.6.1 Chromoblastomycosis, Mycetoma/Eumycetoma, and Other Deep Mycoses -- 1.6.2 Scabies -- 1.6.3 Myiasis -- 1.7 Future Direction -- 1.8 Conclusion -- Acknowledgments -- References -- Chapter 2 Neglected Tropical Diseases, Phytochemicals, Protein Targets, and Mechanisms in Drug Discovery -- List of Abbreviations -- 2.1 Introduction -- 2.2 African Trypanosomiasis -- 2.2.1 Phytochemicals Against African Trypanosomiasis -- 2.3 Buruli Ulcer -- 2.3.1 Phytochemicals Against Buruli Ulcer -- 2.4 Chagas Disease -- 2.4.1 Phytochemicals Against Chagas Disease -- 2.5 Chikungunya -- 2.5.1 Phytochemicals Against Chikungunya -- 2.6 Dengue -- 2.6.1 Phytochemicals Against Dengue -- 2.7 Leishmaniasis -- 2.7.1 Phytochemicals Against Leishmaniasis -- 2.8 Leprosy -- 2.8.1 Indeterminate Leprosy -- 2.8.2 Phytochemicals Against Leprosy -- 2.9 Lymphatic Filariasis -- 2.9.1 Phytochemicals Against Lymphatic Filariasis -- 2.10 Mycetoma -- 2.10.1 Phytochemicals Against Mycetoma.
2.11 Onchocerciasis -- 2.11.1 Phytochemicals Against Onchocerciasis -- 2.12 Rabies -- 2.12.1 Phytochemicals Against Rabies -- 2.13 Scabies -- 2.13.1 Phytochemicals Against Scabies -- 2.14 Schistosomiasis -- 2.14.1 Phytochemicals Against Schistosomiasis -- 2.15 Conclusion -- References -- Chapter 3 Novel Bioactive Lead Compounds for Drug Discovery Against Neglected Tropical Diseases, Leishmaniasis, Lymphatic Filariasis, Trypanosomiasis (African Sleeping Sickness and Chagas Disease), and Schistosomiasis -- List of Abbreviations/Definitions -- 3.1 Introduction -- 3.2 Prevalence of Neglected Tropical Diseases -- 3.2.1 Leishmaniasis -- 3.2.2 Lymphatic Filariasis -- 3.2.3 Trypanosomiasis -- 3.2.3.1 African Trypanosomiasis (African Sleeping Sickness) -- 3.2.3.2 American Trypanosomiasis (Chagas Disease) -- 3.2.4 Schistosomiasis -- 3.3 Novel, Economical, and Efficacious Therapeutics from Medicinal Plants Against NTDs -- 3.3.1 Phytochemicals Effective Against Leishmania Parasite -- 3.3.2 Plants and Phytochemicals Effective Against Filarial Parasite -- 3.3.3 Plants and Phytochemicals Effective Against Trypanosomasis -- 3.3.4 Plants and Phytochemicals Effective Against Schistosomiasis -- 3.4 Future Prospects -- 3.5 Conclusion -- References -- Part II Protozoan Infections -- Chapter 4 Herbal, Nutritional, and Traditional Remedies for Giardiasis: Phytochemicals as Drug Candidates -- List of Abbreviations -- 4.1 Introduction -- 4.1.1 Epidemiology and Symptoms of Giardiasis -- 4.1.2 Life Cycle of G. duodenalis -- 4.1.3 Pathophysiology of Giardial Infection -- 4.1.4 Resistance to Allopathic Drug and Relevance of Herbal Medication -- 4.2 Plant-Based Dietary Supplements for Giardiasis Management -- 4.2.1 Oligosaccharide and Disaccharidase Supplementation -- 4.2.2 Dietary Fiber-Enriched Food -- 4.2.3 Agglutinin from Wheat -- 4.2.4 Vitamin and Mineral Supplements.
4.2.4.1 Vitamin A Supplementation -- 4.2.4.2 Compensation of Vitamin B12 -- 4.2.4.3 Zinc Status Management -- 4.2.5 Fermented Vegetables as Probiotic Source -- 4.2.6 Phenolic Compound Enriched Plant Food -- 4.3 Traditional Treatment of Giardiasis with Herbal Ethnomedicine -- 4.3.1 Hints of Antiprotozoal Medicines from Ancient Communities -- 4.3.2 Domestic Remedies and Alternative Medicine for Giardiasis -- 4.3.3 Applied Spectrum of Ethnopharmacology in Different Continents -- 4.3.3.1 Asian Medicinal Extracts -- 4.3.3.2 African Traditional Medicines -- 4.3.3.3 South American Ethnomedicine -- 4.4 Phytochemical Candidates for Advanced Giardicidal Drug Development -- 4.4.1 Terpenoids -- 4.4.2 Aromatic Ether -- 4.4.3 Alkaloids -- 4.4.4 Organo-sulfur Compounds -- 4.4.5 Lipids and Steroids -- 4.4.6 Phenolic Compounds -- 4.5 Future Prospects -- 4.5.1 Extension of Medicinal Compound Screening -- 4.5.2 Methodical Studies on Toxicology and Drug Adversity -- 4.5.3 Correlation of Herbal Drugs with Molecular Targets of Giardia -- 4.6 Summary, Prospects, and Conclusion -- References -- Chapter 5 Antiprotozoal Activity of Phytochemicals Against Entamoeba histolytica, the Causative Agent of Amoebiasis -- List of Abbreviations -- 5.1 Introduction -- 5.2 Life Cycle of Entamoeba histolytica -- 5.3 Diagnostic Techniques for Identification of E. histolytica -- 5.3.1 Intestinal Amoebiasis -- 5.3.1.1 Microscopy -- 5.3.1.2 Culture and Isoenzyme Analysis -- 5.3.1.3 Antigen Detection Test -- 5.3.1.4 Molecular-Based Test -- 5.3.1.5 Point-of-Care (POC) Test -- 5.4 Treatment of Amoebiasis -- 5.5 Alternative Treatment for Amoebiasis -- 5.6 Chemical Structure of Phytochemicals Effective Against E. histolytica -- 5.7 Possible Mechanisms of Phytochemicals as Antiamoebic -- 5.8 Future Projections -- 5.9 Conclusion -- References -- Chapter 6 Antileishmanial Potentials of Phytochemicals.
6.1 Introduction -- 6.2 Antileishmanial Activity of Propolis -- 6.2.1 Propolis from Turkey -- 6.2.2 Propolis from Brazil -- 6.2.3 Propolis from Portugal -- 6.2.4 Propolis from Cuba -- 6.2.5 Propolis from Ecuador -- 6.3 Antileishmanial Activity of Wild Mushrooms -- 6.4 Antileishmanial Activity of Medicinal Plants from Various Flora -- 6.4.1 Peruvian Flora -- 6.4.2 Ecuadorean Flora -- 6.4.3 Mexican Flora -- 6.4.4 Bolivian Flora -- 6.4.5 Iranian Flora -- 6.5 Antileishmanial Activity of Chemical Constituents -- 6.5.1 Alkaloids -- 6.5.2 Flavonoids -- 6.5.3 Terpenes -- 6.5.4 Glycoglycerolipids -- 6.5.5 Guttiferone A as a Lead Compound for Semisynthesis of Antileishmanial Molecules -- 6.6 Conclusion -- References -- Part III Helminth Infections -- Chapter 7 Prospects of Phytochemicals for the Treatment of Helminthiasis -- List of Abbreviations -- 7.1 Introduction -- 7.1.1 History -- 7.1.2 Prevalence -- 7.2 Molecular Characteristics of Soil-transmitted Helminthiasis -- 7.3 Clinical Features and Pathogenesis -- 7.4 Prevention -- 7.5 Treatment -- 7.6 Plants and Phytochemicals with Anthelmintic Activities -- 7.6.1 Modes of Action of Phytochemical Against the Soil-transmitted Helminthiasis -- 7.7 Scientific Reports of Medicinal Plants with Anthelmintic Properties -- 7.7.1 Adhatoda vasica -- 7.7.2 Allium sativum -- 7.7.3 Baliospermum montanum Muell -- 7.7.4 Butea monosperma -- 7.7.5 Calotropis procera -- 7.7.6 Carica papaya -- 7.7.7 Ficus benghalensis -- 7.7.8 Mimosa pudica -- 7.7.9 Punica granatum -- 7.7.10 Verbascum thapsus -- 7.7.11 Zingiber officinale -- 7.8 Future Prospects -- 7.9 Conclusion -- References -- Chapter 8 Efficacy of Phytochemicals of Medicinal Plants for the Treatment of Human Echinococcosis: Echinococcal Disease, Hydatidosis, or Hydatid Disease Drug Discovery -- List of Abbreviations -- 8.1 Introduction -- 8.2 Molecular Analysis.
8.3 Life Cycle of Echinococcosis -- 8.4 Previous Studies on the Positive Effects of Medicinal Plants and Phytochemicals -- 8.4.1 In vitro and in vivo Effect of Phytochemicals Against Echinococcus Infection -- 8.5 Synthetic Drugs Previously Used for Management of Echinococcosis Disease -- 8.6 Conclusion and Future Prospects -- References -- Chapter 9 Filaricidal Activity of Phytochemicals Against Lymphatic Filariasis -- List of Abbreviations -- 9.1 Introduction -- 9.2 Life Cycle of the Parasite -- 9.3 Synthetic Drugs Used for Treatment of Lymphatic Filariasis -- 9.4 Phytochemicals Used for the Treatment of Lymphatic Filariasis -- 9.4.1 Acacia auriculiformis -- 9.4.2 Aegle marmelos -- 9.4.3 Alnus nepalensis -- 9.4.4 Andrographis paniculata -- 9.4.5 Azadirachta indica -- 9.4.6 Bauhinia racemosa -- 9.4.7 Butea monosperma -- 9.4.8 Caesalpinia bonducella -- 9.4.9 Cardiospermum halicacabum -- 9.4.10 Centratherum anthelminticum -- 9.4.11 Excoecaria agallocha -- 9.4.12 Ficus racemosa -- 9.4.13 Glycyrrhiza glabra -- 9.4.14 Hibiscus sabdariffa -- 9.4.15 Lantana camara -- 9.4.16 Leucas cephalotes -- 9.4.17 Mallotus philippensis -- 9.4.18 Morinda citrifolia -- 9.4.19 Moringa oleifera -- 9.4.20 Plumbago indica -- 9.4.21 Pongamia pinnata -- 9.4.22 Psoralea corylifolia -- 9.4.23 Ricinus communis -- 9.4.24 Saxifraga stracheyion -- 9.4.25 Sphaeranthus indicus -- 9.4.26 Streblus asper -- 9.4.27 Trachyspermum ammi -- 9.4.28 Vitex negundo -- 9.4.29 Xylocarpus granatum -- 9.4.30 Zingiber officinale -- 9.5 Future Perspective -- 9.6 Conclusion -- References -- Chapter 10 Dracunculiasis (Guinea Worm Disease) and Phytochemicals in Drug Discovery -- List of Abbreviations -- 10.1 Introduction -- 10.2 Historical Insights of Dracunculiasis -- 10.3 Prevalence, Burden, and Distribution of Disease -- 10.4 Life Cycle, Pathogenesis, and Clinical Manifestations of Dracunculiasis.
10.5 Prevention and Eradication of Disease.
Record Nr. UNINA-9910830428403321
Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2022]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Phytochemical drug discovery for central nervous system disorders : biochemistry and therapeutic effects / / edited by Chukwuebuka Egbuna, Mithun Rudrapal
Phytochemical drug discovery for central nervous system disorders : biochemistry and therapeutic effects / / edited by Chukwuebuka Egbuna, Mithun Rudrapal
Pubbl/distr/stampa Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2023]
Descrizione fisica 1 online resource (615 pages)
Disciplina 737
Soggetto topico Central nervous system - Diseases
ISBN 1-119-79411-0
1-119-79412-9
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Intro -- Table of Contents -- Title Page -- Copyright Page -- Contributors -- Preface -- 1 Central Nervous System Disorders and Food and Drug Administration-Approved Drugs -- 1.1 Incidence and Prevalence of Major Neurologic Disorders -- 1.2 Etiology -- 1.3 Pathogenesis -- 1.4 Central Nervous System Disorders and Drugs Approved by the Food and Drug Administration -- 1.5 Conclusion -- References -- 2 Drug Discovery from Medicinal Plants against Parkinson's Disease -- 2.1 Pathogenesis of Parkinson's Disease -- 2.2 Natural Dopaminergic Neuroprotective Compounds -- 2.3 Nitrogenated Phytochemicals -- 2.4 Chinese Herbal Medications and Parkinson's Disease -- 2.5 Herbal Medicines from India and Parkinson's Disease -- 2.6 European Plants -- 2.7 α‐Synuclein as a Potential Therapeutic Target -- 2.8 Conclusion -- References -- 3 Drug Discovery from Medicinal Plants against Alzheimer's Disease -- 3.1 Pathogenesis -- 3.2 Treatment Strategies for Alzheimer's Disease -- 3.3 Medicinal Plants Having Effects against Alzheimer's Disease -- 3.4 Natural Products with Proven Anti‐Alzheimer's Activity -- 3.5 Conclusion -- References -- 4 Effects of Medicinal Plants and Phytochemicals on Schizophrenia -- 4.1 Mechanisms of Action Related to Schizophrenia -- 4.2 Ayurvedic Plants Used as Treatment for Schizophrenia and Related Psychoses -- 4.3 Conclusion -- References -- 5 Drug Discovery from Medicinal Plants and Phytochemicals against Neuropathic Pain -- 5.1 Mechanisms of Neuropathic Pain -- 5.2 Animal Models for Studying Neuropathic Pain -- 5.3 Medicinal Plants and Phytochemicals against Neuropathic Pain -- 5.4 Role of Plants and Phytochemicals in Different Neuropathic Pain Models -- 5.5 Future Perspectives -- 5.6 Conclusion -- References -- 6 Brain Function, Stroke, and Medicinal Herbs -- 6.1 Brain Function and Stroke -- 6.2 Strategies for Treatment of Ischemic Stroke.
6.3 Medicinal Plants for the Treatment of Stroke -- 6.4 Natural Products for the Treatment of Stroke -- 6.5 Recent Applications of Nanomedicine for Treatment of Stroke -- 6.6 Conclusion -- References -- 7 Plant‐Based Analgesics -- 7.1 Current Analgesic Drugs and Their Mechanisms of Action -- 7.2 Plant‐Derived Lead Compounds with Analgesic Activities -- 7.3 Analgesic Effects of Medicinal Plants Found in Nigeria -- 7.4 Limitations of Plant‐Based Analgesics -- 7.5 Future Directions and Perspective for Plant‐Based Analgesics -- 7.6 Conclusion -- References -- 8 Medicinal Plants and Phytochemicals against Depression -- 8.1 Causes of Depression -- 8.2 Symptoms of Depression -- 8.3 Diagnosis of Depression -- 8.4 Types of Depression -- 8.5 Treatment of Depression -- 8.6 Conclusion -- References -- 9 Anti‐inflammatory Agents from Medicinal Plants -- 9.1 Role of Neuroinflammation in Neurodegenerative Diseases -- 9.2 Neuroinflammatory Drugs -- 9.3 Medicinal Plants as Sources of Anti‐inflammatory Agents -- 9.4 Bioactive Compounds as Anti‐inflammatory Agents -- 9.5 Conclusion -- References -- 10 Plant‐Based Products and Phytochemicals against Viral Infections of the Central Nervous System -- 10.1 Viral Infections of the Central Nervous System -- 10.2 Plant and Phytochemicals as Antiviral Agents for Central Nervous System Viral Infections -- 10.3 Controlling Vectors of Viral Diseases of the Central Nervous System -- 10.4 Future Perspectives -- 10.5 Conclusion -- References -- 11 Fruits and Nutraceuticals for the Prevention and Treatment of Central Nervous System Disorders -- 11.1 Fruits for Cognition and Brain Health -- 11.2 Nutraceuticals in Ameliorating Neurodegeneration -- 11.3 Nutraceuticals in Alzheimer's Disease -- 11.4 Nutraceuticals in Parkinson's Disease -- 11.5 Nutraceuticals in Depression -- 11.6 Nutraceuticals in Psychotic Disorders -- 11.7 Conclusion.
References -- 12 Neurorestorative Potential of Medicinal Plants and Their Phytochemicals -- 12.1 Therapeutic Value of Some Medicinal Plants and their Importance -- 12.2 Types of Medicinal Plants and Their Uses -- 12.3 Phytochemicals -- 12.4 Phytochemical Constituents in Some Medicinal Plants -- 12.5 The Brain -- 12.6 Brain Conditions -- 12.7 Protective Effects of Medicinal Plants on the Brain -- 12.8 Conclusion -- References -- 13 Neurotransmitter Modulation by Phytochemicals -- 13.1 Sources, Structures, and Classifications of Phytochemicals -- 13.2 Neurotransmitters and Their Functions -- 13.3 Modulation of Cholinergic Signaling by Phytochemicals -- 13.4 Effect of Phytochemicals on GABAergic Signaling -- 13.5 Effect of Phytochemicals on Glutamatergic Signaling -- 13.6 Modulation of Serotonergic and Dopaminergic Signaling by Phytochemicals -- 13.7 Conclusion -- Acknowledgments -- References -- 14 Antipyretic Agents from Plant Origins -- 14.1 Pyrexia Development, Its Mechanisms, and the Roles of Plant Metabolites as Antipyretics -- 14.2 Antipyretic Agents of Plant Origin -- 14.3 Conclusion and Future Perspectives -- References -- 15 Medicinal Herbs against Central Nervous System Disorders -- 15.1 Medicinal Plants as Interventions for Central Nervous System Disorders -- 15.2 Some Medicinal Plants with Neuroprotective Action on Central Nervous System Disorders -- 15.3 Some Central Nervous System Disorders and Medicinal Plant Interventions -- 15.4 Some Mechanistic Actions of Medicinal Herbs against Central Nervous System Disorders -- 15.5 Conclusion -- References -- 16 Important Antihistaminic Plants and Their Potential Role in Health -- 16.1 Antihistaminic Plants -- 16.2 Bioactive Compounds with Antihistaminic Activities -- 16.3 Conclusion -- References -- 17 Effect of Plant‐Based Anticonvulsant Products and Phytochemicals.
17.1 Types of Epileptic Seizures -- 17.2 Basic Mechanisms of Epilepsy -- 17.3 Epilepsy and Oxidative Stress -- 17.4 Epilepsy and Inflammation -- 17.5 Tests for Seizure Induction -- 17.6 Medicinal Plants Used to Treat Epilepsy -- 17.7 Conclusion -- References -- 18 Application of Nanophytomedicine for the Treatment of Central Nervous System Disorders -- 18.1 Neurodegenerative Disease and the Blood-Brain Barrier -- 18.2 Nano Approaches to Central Nervous System Drug Delivery -- 18.3 Nanophytomedicine for Treatment of Central Nervous System Disorders -- 18.4 Challenges in Nanophytomedicine -- 18.5 Conclusion -- References -- Index -- End User License Agreement.
Record Nr. UNINA-9910830955703321
Hoboken, New Jersey : , : John Wiley & Sons, Inc., , [2023]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui